3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Cytarabine
5
Whole-Body Irradiation
3
Specimen Handling
3
Injections
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
fludarabine
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
selinexor
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
tipifarnib
×
30 days
×
Clear all
No trials found.